Glucocorticoids and the genesis of depressive illness. A psychobiological model

doi:10.1192/bjp.164.3.365

This Article

	Full Text (PDF)
	Submit an eLetter
	Alert me when this article is cited
	Alert me when eLetters are posted
	Alert me if a correction is posted
	Citation Map

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar
	Citing Articles via Scopus

Google Scholar

	Articles by Dinan, T. G.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Dinan, T. G.

The British Journal of Psychiatry 164: 365-371 (1994)
© 1994 The Royal College of Psychiatrists

Glucocorticoids and the genesis of depressive illness. A psychobiological model

TG Dinan
St Bartholomew's Hospital, London.

Abnormalities in the hypothalamic-pituitary-adrenal axis (HPA) have been the most consistently demonstrated biological markers in depressive illness. Numerous other neuroendocrine disturbances have also been described, including blunted clonidine-induced growth hormone release and blunted fenfluramine-induced prolactin release. These disturbances are generally interpreted in terms of monoaminergic receptor dysfunction. The theory presented here suggests that chronic stress which activates the HPA will in certain susceptible people produce changes in central monoamines. The high level of glucocorticoid receptors on such central neurons is postulated as mediating the alterations. Thus monoamine abnormalities, rather than being a core aetiological feature of depression, are seen as secondary to HPA overdrive.

This article has been cited by other articles:

F. Spiga, L. R Harrison, S. A Wood, C. P MacSweeney, F. J Thomson, M. Craighead, M. Grassie, and S. L Lightman
Effect of the glucocorticoid receptor antagonist Org 34850 on fast and delayed feedback of corticosterone release
J. Endocrinol., February 1, 2008; 196(2): 323 - 330.
[Abstract] [Full Text] [PDF]

R. H. McAllister-Williams, A. E. Massey, and G. Fairchild
Repeated cortisol administration attenuates the EEG response to buspirone in healthy volunteers: evidence for desensitization of the 5-HT1 A autoreceptor
J Psychopharmacol, November 1, 2007; 21(8): 826 - 832.
[Abstract] [PDF]

C. Firk and C. R. Markus
Review: Serotonin by stress interaction: a susceptibility factor for the development of depression?
J Psychopharmacol, July 1, 2007; 21(5): 538 - 544.
[Abstract] [PDF]

J. Cromby
Between Constructionism and Neuroscience: The Societal Co-constitution of Embodied Subjectivity
Theory Psychology, December 1, 2004; 14(6): 797 - 821.
[Abstract] [PDF]

A. J. Cleare
The Neuroendocrinology of Chronic Fatigue Syndrome
Endocr. Rev., April 1, 2003; 24(2): 236 - 252.
[Abstract] [Full Text] [PDF]

J. D. Johnson, K. A. O'Connor, M. K. Hansen, L. R. Watkins, and S. F. Maier
Effects of prior stress on LPS-induced cytokine and sickness responses
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2003; 284(2): R422 - R432.
[Abstract] [Full Text] [PDF]

E. M. Cassidy, D. Manning, S. Byrne, E. Bolger, F. Murray, N. Sharifi, E. Wallace, M. Keogan, and V. O'Keane
Acute effects of low-dose interferon-{alpha} on serum cortisol and plasma interleukin-6
J Psychopharmacol, May 1, 2002; 16(3): 230 - 234.
[Abstract] [PDF]

M.-S. Man, A. H. Young, and R. H. McAllister-Williams
Corticosterone modulation of somatodendritic 5-HT1A receptor function in mice
J Psychopharmacol, May 1, 2002; 16(3): 245 - 252.
[Abstract] [PDF]

P.J. COWEN
Cortisol, serotonin and depression: all stressed out?
The British Journal of Psychiatry, February 1, 2002; 180(2): 99 - 100.
[Full Text] [PDF]

P. L. STRICKLAND, J. F. W. DEAKIN, C. PERCIVAL, J. DIXON, R. A. GATER, and D. P. GOLDBERG
Bio-social origins of depression in the community: Interactions between social adversity, cortisol and serotonin neurotransmission
The British Journal of Psychiatry, February 1, 2002; 180(2): 168 - 173.
[Abstract] [Full Text] [PDF]

A. J. Cleare, J. Miell, E. Heap, S. Sookdeo, L. Young, G. S. Malhi, and V. O'Keane
Hypothalamo-Pituitary-Adrenal Axis Dysfunction in Chronic Fatigue Syndrome, and the Effects of Low-Dose Hydrocortisone Therapy
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3545 - 3554.
[Abstract] [Full Text] [PDF]

R. WHALE, E. M. CLIFFORD, Z. BHAGWAGAR, and PHILIP. J. COWEN
Decreased sensitivity of 5-HT1D receptors in melancholic depression
The British Journal of Psychiatry, May 1, 2001; 178(5): 454 - 457.
[Abstract] [Full Text] [PDF]

G. Lambert, M. Johansson, H. Agren, and P. Friberg
Reduced Brain Norepinephrine and Dopamine Release in Treatment-Refractory Depressive Illness: Evidence in Support of the Catecholamine Hypothesis of Mood Disorders
Arch Gen Psychiatry, August 1, 2000; 57(8): 787 - 793.
[Abstract] [Full Text] [PDF]

A. Bhargava, O. C. Meijer, M. F. Dallman, and D. Pearce
Plasma Membrane Calcium Pump Isoform 1 Gene Expression Is Repressed by Corticosterone and Stress in Rat Hippocampus
J. Neurosci., May 1, 2000; 20(9): 3129 - 3138.
[Abstract] [Full Text] [PDF]

B. Leonard
Clinical implications of mechanisms of action of antidepressants
Adv. Psychiatr. Treat., May 1, 2000; 6(3): 178 - 186.
[Full Text]

E. M. Cassidy and V. O'Keane
Depression and interferon-alpha therapy
The British Journal of Psychiatry, May 1, 2000; 176 (5): 494a - 494a.
[Full Text] [PDF]

O. G. Cameron
Psychopharmacology
Psychosom Med, September 1, 1999; 61(5): 585 - 590.
[Full Text] [PDF]

T. G. Dinan, E. Lavelle, L. V. Scott, J. Newell-Price, S. Medbak, and A. B. Grossman
Desmopressin Normalizes the Blunted Adrenocorticotropin Response to Corticotropin-Releasing Hormone in Melancholic Depression: Evidence of Enhanced Vasopressinergic Responsivity
J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2238 - 2240.
[Abstract] [Full Text]

P. Chen, M. Ganguli, B. H. Mulsant, and S. T. DeKosky
The Temporal Relationship Between Depressive Symptoms and Dementia: A Community-Based Prospective Study
Arch Gen Psychiatry, March 1, 1999; 56(3): 261 - 266.
[Abstract] [Full Text] [PDF]

				R. H. McAllister-Williams, A. E. Massey, and G. Fairchild Repeated cortisol administration attenuates the EEG response to buspirone in healthy volunteers: evidence for desensitization of the 5-HT1 A autoreceptor J Psychopharmacol, November 1, 2007; 21(8): 826 - 832. [Abstract] [PDF]

				C. Firk and C. R. Markus Review: Serotonin by stress interaction: a susceptibility factor for the development of depression? J Psychopharmacol, July 1, 2007; 21(5): 538 - 544. [Abstract] [PDF]

				J. Cromby Between Constructionism and Neuroscience: The Societal Co-constitution of Embodied Subjectivity Theory Psychology, December 1, 2004; 14(6): 797 - 821. [Abstract] [PDF]

				A. J. Cleare The Neuroendocrinology of Chronic Fatigue Syndrome Endocr. Rev., April 1, 2003; 24(2): 236 - 252. [Abstract] [Full Text] [PDF]

				J. D. Johnson, K. A. O'Connor, M. K. Hansen, L. R. Watkins, and S. F. Maier Effects of prior stress on LPS-induced cytokine and sickness responses Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2003; 284(2): R422 - R432. [Abstract] [Full Text] [PDF]

				E. M. Cassidy, D. Manning, S. Byrne, E. Bolger, F. Murray, N. Sharifi, E. Wallace, M. Keogan, and V. O'Keane Acute effects of low-dose interferon-{alpha} on serum cortisol and plasma interleukin-6 J Psychopharmacol, May 1, 2002; 16(3): 230 - 234. [Abstract] [PDF]

				M.-S. Man, A. H. Young, and R. H. McAllister-Williams Corticosterone modulation of somatodendritic 5-HT1A receptor function in mice J Psychopharmacol, May 1, 2002; 16(3): 245 - 252. [Abstract] [PDF]

				P.J. COWEN Cortisol, serotonin and depression: all stressed out? The British Journal of Psychiatry, February 1, 2002; 180(2): 99 - 100. [Full Text] [PDF]

				P. L. STRICKLAND, J. F. W. DEAKIN, C. PERCIVAL, J. DIXON, R. A. GATER, and D. P. GOLDBERG Bio-social origins of depression in the community: Interactions between social adversity, cortisol and serotonin neurotransmission The British Journal of Psychiatry, February 1, 2002; 180(2): 168 - 173. [Abstract] [Full Text] [PDF]

				A. J. Cleare, J. Miell, E. Heap, S. Sookdeo, L. Young, G. S. Malhi, and V. O'Keane Hypothalamo-Pituitary-Adrenal Axis Dysfunction in Chronic Fatigue Syndrome, and the Effects of Low-Dose Hydrocortisone Therapy J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3545 - 3554. [Abstract] [Full Text] [PDF]

				R. WHALE, E. M. CLIFFORD, Z. BHAGWAGAR, and PHILIP. J. COWEN Decreased sensitivity of 5-HT1D receptors in melancholic depression The British Journal of Psychiatry, May 1, 2001; 178(5): 454 - 457. [Abstract] [Full Text] [PDF]

				G. Lambert, M. Johansson, H. Agren, and P. Friberg Reduced Brain Norepinephrine and Dopamine Release in Treatment-Refractory Depressive Illness: Evidence in Support of the Catecholamine Hypothesis of Mood Disorders Arch Gen Psychiatry, August 1, 2000; 57(8): 787 - 793. [Abstract] [Full Text] [PDF]

				A. Bhargava, O. C. Meijer, M. F. Dallman, and D. Pearce Plasma Membrane Calcium Pump Isoform 1 Gene Expression Is Repressed by Corticosterone and Stress in Rat Hippocampus J. Neurosci., May 1, 2000; 20(9): 3129 - 3138. [Abstract] [Full Text] [PDF]

				B. Leonard Clinical implications of mechanisms of action of antidepressants Adv. Psychiatr. Treat., May 1, 2000; 6(3): 178 - 186. [Full Text]

				E. M. Cassidy and V. O'Keane Depression and interferon-alpha therapy The British Journal of Psychiatry, May 1, 2000; 176 (5): 494a - 494a. [Full Text] [PDF]

				O. G. Cameron Psychopharmacology Psychosom Med, September 1, 1999; 61(5): 585 - 590. [Full Text] [PDF]

				T. G. Dinan, E. Lavelle, L. V. Scott, J. Newell-Price, S. Medbak, and A. B. Grossman Desmopressin Normalizes the Blunted Adrenocorticotropin Response to Corticotropin-Releasing Hormone in Melancholic Depression: Evidence of Enhanced Vasopressinergic Responsivity J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2238 - 2240. [Abstract] [Full Text]

				P. Chen, M. Ganguli, B. H. Mulsant, and S. T. DeKosky The Temporal Relationship Between Depressive Symptoms and Dementia: A Community-Based Prospective Study Arch Gen Psychiatry, March 1, 1999; 56(3): 261 - 266. [Abstract] [Full Text] [PDF]